Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-10-28

FDA Approved: NICARDIPINE HYDROCHLORIDE — Original Application (Sagent Pharmaceuticals)

View source ↗

Summary

FDA approved the original application for Nicardipine hydrochloride from Sagent Pharmaceuticals (ANDA 219608), establishing a generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nicardipine hydrochloride (Nicardipine)

Snippet

ORIG AP for NICARDIPINE HYDROCHLORIDE (NICARDIPINE HYDROCHLORIDE)